The French drugmaker is paying $17.5 million upfront to kick off the collaboration ... ambitions in immuno-oncology are spearheaded by its Regeneron-partnered PD-1 checkpoint inhibitor Libtayo ...

The study will kick off by testing 300,000 samples – 250,000 first and 50,000 second samples - at the Regeneron Genetics Center in the US, with funding for that stage of the project provided by ...

RIVERFEST Limerick 2025 will present a diverse range of activities and events designed to delight visitors of all ages from ...

Regeneron’s Eylea franchise remains resilient despite biosimilar competition, with Eylea HD showing strong performance and new innovations like a pre-filled syringe on the horizon. Dupixent ...

Regeneron Pharmaceuticals saw its share price decline by 10% over the past week. The recent approval of Dupixent for COPD in Japan was expected to bolster investor confidence, yet the broader ...

The S&P 500 Index ($SPX) (SPY) today is up +0.64%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.29%, and the Nasdaq ...

The S&P 500 Index ($SPX) (SPY) today is down -0.51%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.73%, and the ...

All three major averages (DJI, GSPC, IXIC) opened Wednesday's trading session in the red, weighed down by escalating trade ...

Stock indexes have erased early losses to trade higher at midday as US reciprocal tariffs kick in. The tariffs have sparked a crisis of confidence in the dollar, prompting the selling of dollar ...

Regeneron Pharmaceuticals Inc REGN raises some concerns due to its significant presence in Ireland. If tariffs are applied, they would likely increase the cost of goods sold since companies often ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...